All SARS-CoV-2 / COVID-19 at the Institut Pasteur

An epidemic of pneumonia of viral appearance and of unknown etiology emerged in the city of Wuhan (Hubei province, China) in December 2019. On January 9, 2020, the discovery of a new coronavirus (first called 2019-nCoV, then SARS-CoV-2) was officially announced by the Chinese health authorities and the World Health Organization (WHO). This coronavirus is the agent responsible for the new infectious respiratory disease called Covid-19 (CoronaVIrus Disease 2019).


The Institut Pasteur (Paris) and the Institut Pasteur International Network have been extremely active worldwide in responding with science to the pandemic caused by the SARS-CoV-2 coronavirus, responsible for Covid-19 disease.


Here are the news, press releases and videos from the Institut Pasteur (Paris), which was mobilized as soon as the first cases were announced, following the declaration of the epidemic by the Chinese authorities.

On April 7, 2021, the European Medical Agency (EMA) concluded that thrombosis in combination with thrombocytopenia has been identified as a likely adverse event following vaccination with the COVID-19 vaccine Vaxzevria. Researchers from the Mathematical Modelling of Infectious Diseases Unit at the Institut Pasteur used a mathematical model to assess its benefits and risks in metropolitan France accounting for the indirect effect of vaccination as well as the availability of alternative vaccines.
Cellules bronchiques humaines infectées par SARS-CoV-2
The Delta variant was detected for the first time in India in October 2020 and has since spread throughout the world. It is now dominant in many countries and regions (India, the UK, Portugal, Russia, etc.) and is predicted to be the most prevalent variant in Europe within weeks or months. Epidemiological studies have shown that the Delta variant is more transmissible than other variants.
Loss of smell, or anosmia, is one of the earliest and most commonly reported symptoms of COVID-19. But the mechanisms involved had yet to be clarified. Scientists from the Institut Pasteur, the CNRS, Inserm, Université de Paris and the Paris Public Hospital Network (AP-HP) determined the mechanisms involved in the loss of smell in patients infected with SARS-CoV-2 at different stages of the disease. They discovered that SARS-CoV-2 infects sensory neurons and causes persistent epithelial and olfactory nervous system inflammation.
Crédit : Institut Pasteur. Image par Rémy Robinot, Mathieu Hubert, Vincent Michel, Olivier Schwartz et Lisa Chakrabarti, et colorisée par Jean Marc Panaud

Scientific Publications




Covid-19 disease fact sheet (novel coronavirus)

Fiche Maladie Covid-19 - Institut Pasteur

All the information about Covid-19 disease, caused by the SARS-CoV-2 coronavirus (cause, symptoms, transmission, prevention, treatment, etc.). The Covid-19 fact sheet is updated regularly.




Coronavirus : attention aux fausses informations circulant sur les réseaux sociaux - Institut Pasteur

Coronavirus SARS-CoV-2 and Covid-19: beware of false information


Back to top